Published in

Elsevier, European Neuropsychopharmacology, (13), p. S7-S9

DOI: 10.1016/s0924-977x(03)90006-x

Elsevier, European Neuropsychopharmacology, 6(13), p. 453-458

DOI: 10.1016/j.euroneuro.2003.08.006

Links

Tools

Export citation

Search in Google Scholar

Brain imaging studies in human addicts

Journal article published in 2003 by Mark R. C. Daglish ORCID, David J. Nutt
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Addiction provides fertile ground for the application of the tools of functional neuroimaging. They can be divided into studies of neural activity and neurotransmitter function. Using the former, both opiates and stimulants cause a global decrease in brain metabolism. Against this background, acute doses have still been shown to produce relative increases in brain activation in specific regions, e.g., anterior cingulate, thalamus, and amygdala. These are also regions frequently found with cue-exposure paradigms. Our own work on cue-exposure has shown that heroin-related stimuli provoke activation of the anterior cingulate and orbitofrontal regions. Brain metabolism has also been shown to increase in drug withdrawal from alcohol and cocaine. Neurotransmitter studies have shown that in alcohol dependence, GABA(A)-benzodiazepine (GABA-BDZ) receptors are reduced in a number of brain regions and suggest that there may be 'capacity within the system' in some benzodiazepine functions, but tolerance to others, e.g., time asleep. Finally, C-11-Ro15-4513 offers new opportunities for imaging the GABA-BDZ system. (C) 2003 Elsevier B.V./ECNP. All rights reserved.